DOI:
10.1055/s-00029027
Journal of Pediatric Genetics
LinksClose Window
References
Sabbatini M, Capone D, Gallo R , et al.
EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects.
Fundam Clin Pharmacol 2009;
23 (5) 617-624
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.